HAVCR2 and leukemia: Enhanced expression of miR-34a in TIM3 positive leukemia stem cells (LSC) from AML children inhibits the clone expansion, progression and metastasis of leukemia, suggesting that miR-34a is a key regulator which could be taken into consideration as a novel therapeutic agent against LSC (94).